| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dietary Supplements | 67 | 2025 | 239 | 13.710 |
Why?
|
| Micronutrients | 35 | 2024 | 48 | 10.460 |
Why?
|
| Child Development | 30 | 2025 | 75 | 7.850 |
Why?
|
| Docosahexaenoic Acids | 21 | 2025 | 91 | 6.610 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 22 | 2021 | 28 | 6.030 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 19 | 2022 | 62 | 5.630 |
Why?
|
| Iron | 24 | 2024 | 116 | 5.120 |
Why?
|
| Pregnancy | 88 | 2025 | 1181 | 5.070 |
Why?
|
| Nutritional Status | 24 | 2025 | 77 | 4.680 |
Why?
|
| Birth Weight | 21 | 2023 | 63 | 4.100 |
Why?
|
| Malnutrition | 16 | 2025 | 31 | 4.050 |
Why?
|
| Infant | 85 | 2025 | 996 | 3.950 |
Why?
|
| Body Height | 22 | 2021 | 57 | 3.830 |
Why?
|
| Female | 171 | 2025 | 15156 | 3.570 |
Why?
|
| Diet | 22 | 2025 | 231 | 3.550 |
Why?
|
| Vietnam | 26 | 2025 | 44 | 3.360 |
Why?
|
| Child, Preschool | 60 | 2025 | 1137 | 3.330 |
Why?
|
| Folic Acid | 15 | 2024 | 32 | 3.260 |
Why?
|
| Anemia, Iron-Deficiency | 16 | 2021 | 27 | 3.100 |
Why?
|
| Infant Nutritional Physiological Phenomena | 17 | 2022 | 36 | 3.060 |
Why?
|
| Humans | 199 | 2025 | 28121 | 3.030 |
Why?
|
| Infant, Newborn | 56 | 2025 | 873 | 2.910 |
Why?
|
| Adult | 94 | 2025 | 7757 | 2.700 |
Why?
|
| Growth Disorders | 15 | 2025 | 21 | 2.650 |
Why?
|
| Mothers | 15 | 2025 | 121 | 2.630 |
Why?
|
| Prenatal Care | 14 | 2023 | 40 | 2.500 |
Why?
|
| Developing Countries | 19 | 2019 | 50 | 2.420 |
Why?
|
| Preconception Care | 6 | 2019 | 17 | 2.390 |
Why?
|
| Anemia | 15 | 2025 | 43 | 2.380 |
Why?
|
| Child | 48 | 2025 | 2242 | 2.320 |
Why?
|
| Double-Blind Method | 33 | 2025 | 414 | 2.290 |
Why?
|
| Mexico | 27 | 2021 | 88 | 2.270 |
Why?
|
| Body Mass Index | 21 | 2025 | 398 | 2.120 |
Why?
|
| Young Adult | 46 | 2025 | 2731 | 2.070 |
Why?
|
| Pregnancy Complications | 10 | 2017 | 111 | 2.040 |
Why?
|
| Weight Gain | 8 | 2022 | 74 | 2.030 |
Why?
|
| Child Nutrition Disorders | 5 | 2025 | 6 | 2.000 |
Why?
|
| Body Weight | 18 | 2021 | 250 | 2.000 |
Why?
|
| Postpartum Period | 8 | 2024 | 72 | 1.950 |
Why?
|
| Growth | 10 | 2012 | 24 | 1.880 |
Why?
|
| Adiposity | 6 | 2021 | 94 | 1.850 |
Why?
|
| Cognition | 6 | 2023 | 322 | 1.750 |
Why?
|
| Fetal Development | 5 | 2024 | 21 | 1.710 |
Why?
|
| Prenatal Exposure Delayed Effects | 7 | 2023 | 108 | 1.710 |
Why?
|
| Adolescent | 44 | 2025 | 3123 | 1.700 |
Why?
|
| Cardiovascular Diseases | 8 | 2025 | 366 | 1.690 |
Why?
|
| Breast Feeding | 15 | 2024 | 92 | 1.620 |
Why?
|
| Iron, Dietary | 11 | 2017 | 16 | 1.620 |
Why?
|
| Pregnancy Outcome | 12 | 2019 | 131 | 1.600 |
Why?
|
| Fatty Acids, Omega-3 | 6 | 2019 | 35 | 1.570 |
Why?
|
| Feeding Behavior | 10 | 2025 | 102 | 1.520 |
Why?
|
| Infant, Small for Gestational Age | 7 | 2016 | 12 | 1.510 |
Why?
|
| Thinness | 7 | 2025 | 18 | 1.500 |
Why?
|
| Rural Population | 16 | 2018 | 107 | 1.470 |
Why?
|
| Male | 80 | 2025 | 13487 | 1.440 |
Why?
|
| Metabolic Syndrome | 4 | 2023 | 78 | 1.430 |
Why?
|
| India | 27 | 2025 | 143 | 1.410 |
Why?
|
| Fatty Acid Desaturases | 3 | 2021 | 15 | 1.410 |
Why?
|
| Vitamin A | 10 | 2012 | 25 | 1.400 |
Why?
|
| Mental Health | 4 | 2021 | 99 | 1.340 |
Why?
|
| Child Nutritional Physiological Phenomena | 7 | 2023 | 21 | 1.310 |
Why?
|
| Pregnant Women | 2 | 2022 | 23 | 1.290 |
Why?
|
| Pediatric Obesity | 5 | 2021 | 69 | 1.280 |
Why?
|
| Anthropometry | 14 | 2025 | 94 | 1.270 |
Why?
|
| Randomized Controlled Trials as Topic | 16 | 2020 | 385 | 1.230 |
Why?
|
| Gestational Age | 8 | 2017 | 141 | 1.200 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 554 | 1.190 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2017 | 36 | 1.160 |
Why?
|
| Fetal Growth Retardation | 5 | 2016 | 30 | 1.140 |
Why?
|
| Maternal Exposure | 2 | 2018 | 17 | 1.070 |
Why?
|
| Longitudinal Studies | 21 | 2025 | 413 | 1.050 |
Why?
|
| Prevalence | 21 | 2022 | 494 | 1.050 |
Why?
|
| Overweight | 8 | 2021 | 111 | 1.040 |
Why?
|
| Vitamin A Deficiency | 7 | 2014 | 9 | 1.030 |
Why?
|
| Patient Compliance | 5 | 2016 | 75 | 1.030 |
Why?
|
| Body Composition | 12 | 2024 | 265 | 0.990 |
Why?
|
| Milk, Human | 8 | 2023 | 82 | 0.980 |
Why?
|
| Obesity | 8 | 2023 | 668 | 0.970 |
Why?
|
| Infant, Low Birth Weight | 5 | 2022 | 23 | 0.950 |
Why?
|
| Socioeconomic Factors | 18 | 2024 | 248 | 0.940 |
Why?
|
| Mother-Child Relations | 1 | 2025 | 14 | 0.940 |
Why?
|
| Energy Intake | 11 | 2023 | 69 | 0.920 |
Why?
|
| Premature Birth | 6 | 2023 | 50 | 0.920 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2020 | 6 | 0.920 |
Why?
|
| Babuvirus | 2 | 2014 | 2 | 0.920 |
Why?
|
| Medication Adherence | 2 | 2017 | 47 | 0.910 |
Why?
|
| Follow-Up Studies | 17 | 2021 | 1014 | 0.900 |
Why?
|
| Zinc | 8 | 2014 | 59 | 0.900 |
Why?
|
| Parity | 8 | 2025 | 50 | 0.890 |
Why?
|
| Cohort Effect | 2 | 2020 | 3 | 0.840 |
Why?
|
| Motor Skills | 4 | 2018 | 34 | 0.810 |
Why?
|
| Guatemala | 25 | 2024 | 30 | 0.810 |
Why?
|
| Health Education | 3 | 2020 | 71 | 0.800 |
Why?
|
| Food Preferences | 1 | 2022 | 20 | 0.800 |
Why?
|
| Behavior Therapy | 2 | 2020 | 29 | 0.790 |
Why?
|
| Transients and Migrants | 1 | 2022 | 3 | 0.770 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2012 | 6 | 0.760 |
Why?
|
| Risk Factors | 16 | 2025 | 2084 | 0.750 |
Why?
|
| Residence Characteristics | 2 | 2024 | 104 | 0.740 |
Why?
|
| Vitamins | 7 | 2024 | 23 | 0.730 |
Why?
|
| Elettaria | 3 | 2019 | 3 | 0.720 |
Why?
|
| Prospective Studies | 14 | 2023 | 1249 | 0.710 |
Why?
|
| Blood Pressure | 5 | 2025 | 355 | 0.710 |
Why?
|
| Metabolome | 1 | 2021 | 68 | 0.710 |
Why?
|
| Adipokines | 1 | 2020 | 9 | 0.700 |
Why?
|
| Head | 5 | 2015 | 18 | 0.700 |
Why?
|
| Inflammation | 5 | 2020 | 626 | 0.700 |
Why?
|
| Educational Status | 10 | 2012 | 113 | 0.690 |
Why?
|
| Human Development | 1 | 2020 | 4 | 0.680 |
Why?
|
| Lactation | 7 | 2025 | 57 | 0.680 |
Why?
|
| Infant Nutrition Disorders | 1 | 2020 | 1 | 0.670 |
Why?
|
| Diarrhea | 7 | 2023 | 56 | 0.660 |
Why?
|
| Nutritional Sciences | 1 | 2019 | 12 | 0.660 |
Why?
|
| Phenylketonurias | 4 | 2023 | 4 | 0.650 |
Why?
|
| Hemoglobins | 10 | 2021 | 118 | 0.650 |
Why?
|
| Food, Fortified | 8 | 2021 | 22 | 0.640 |
Why?
|
| Cohort Studies | 13 | 2025 | 886 | 0.630 |
Why?
|
| Cross-Sectional Studies | 18 | 2025 | 968 | 0.620 |
Why?
|
| Air Pollution, Indoor | 3 | 2024 | 13 | 0.620 |
Why?
|
| Arm | 2 | 2015 | 37 | 0.600 |
Why?
|
| DNA Methylation | 3 | 2014 | 152 | 0.590 |
Why?
|
| Maternal Health Services | 3 | 2012 | 9 | 0.590 |
Why?
|
| Environmental Pollutants | 1 | 2018 | 34 | 0.570 |
Why?
|
| Nutritional Requirements | 5 | 2013 | 9 | 0.560 |
Why?
|
| Rural Health | 4 | 2013 | 14 | 0.560 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2018 | 296 | 0.550 |
Why?
|
| Parenting | 2 | 2017 | 56 | 0.540 |
Why?
|
| Menstruation | 1 | 2017 | 9 | 0.540 |
Why?
|
| Immune System | 2 | 2013 | 29 | 0.530 |
Why?
|
| Nutrition Policy | 7 | 2014 | 22 | 0.530 |
Why?
|
| Linear Models | 10 | 2022 | 203 | 0.520 |
Why?
|
| Physical Examination | 1 | 2017 | 51 | 0.520 |
Why?
|
| Nutrition Assessment | 4 | 2015 | 16 | 0.510 |
Why?
|
| Interferon-gamma | 2 | 2016 | 107 | 0.510 |
Why?
|
| Social Class | 6 | 2016 | 81 | 0.510 |
Why?
|
| Schools | 5 | 2025 | 79 | 0.500 |
Why?
|
| Attention | 1 | 2016 | 90 | 0.490 |
Why?
|
| Health Plan Implementation | 2 | 2012 | 9 | 0.490 |
Why?
|
| Education | 3 | 2010 | 33 | 0.480 |
Why?
|
| Genome, Viral | 2 | 2019 | 31 | 0.480 |
Why?
|
| Maternal Welfare | 2 | 2014 | 4 | 0.470 |
Why?
|
| Child Welfare | 2 | 2014 | 39 | 0.470 |
Why?
|
| Aphids | 1 | 2014 | 1 | 0.470 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2016 | 66 | 0.470 |
Why?
|
| Insect Vectors | 1 | 2014 | 12 | 0.470 |
Why?
|
| Interleukins | 1 | 2016 | 112 | 0.470 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 248 | 0.460 |
Why?
|
| Surveys and Questionnaires | 11 | 2020 | 969 | 0.460 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2011 | 6 | 0.450 |
Why?
|
| alpha-Linolenic Acid | 2 | 2011 | 4 | 0.450 |
Why?
|
| Reassortant Viruses | 1 | 2014 | 1 | 0.450 |
Why?
|
| Folic Acid Deficiency | 1 | 2014 | 5 | 0.440 |
Why?
|
| United States | 13 | 2024 | 2149 | 0.440 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2014 | 9 | 0.440 |
Why?
|
| Nutrition Surveys | 8 | 2025 | 31 | 0.440 |
Why?
|
| Ferritins | 7 | 2014 | 27 | 0.430 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2016 | 32 | 0.430 |
Why?
|
| Plant Diseases | 5 | 2019 | 39 | 0.420 |
Why?
|
| Reproducibility of Results | 8 | 2023 | 773 | 0.420 |
Why?
|
| Infant Food | 6 | 2018 | 11 | 0.420 |
Why?
|
| Biomarkers | 5 | 2020 | 755 | 0.420 |
Why?
|
| Multivariate Analysis | 9 | 2016 | 300 | 0.410 |
Why?
|
| Petroleum | 2 | 2024 | 34 | 0.410 |
Why?
|
| Poverty | 7 | 2024 | 88 | 0.410 |
Why?
|
| Calcium Compounds | 1 | 2012 | 3 | 0.400 |
Why?
|
| Sodium Hydroxide | 1 | 2012 | 9 | 0.400 |
Why?
|
| Anesthesia, Closed-Circuit | 1 | 2012 | 3 | 0.400 |
Why?
|
| Genetic Variation | 1 | 2014 | 243 | 0.400 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2012 | 3 | 0.400 |
Why?
|
| Evoked Potentials, Visual | 1 | 2012 | 5 | 0.400 |
Why?
|
| Ventilators, Mechanical | 1 | 2012 | 10 | 0.390 |
Why?
|
| Fertility | 2 | 2005 | 58 | 0.390 |
Why?
|
| Oxides | 1 | 2012 | 14 | 0.390 |
Why?
|
| Ecosystem | 1 | 2014 | 225 | 0.390 |
Why?
|
| Weight Reduction Programs | 3 | 2017 | 9 | 0.390 |
Why?
|
| Lipids | 4 | 2023 | 208 | 0.380 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 145 | 0.370 |
Why?
|
| Common Cold | 1 | 2011 | 2 | 0.370 |
Why?
|
| Mexican Americans | 2 | 2002 | 13 | 0.370 |
Why?
|
| Domestic Violence | 1 | 2011 | 7 | 0.360 |
Why?
|
| Cooking | 4 | 2024 | 13 | 0.360 |
Why?
|
| Health Policy | 1 | 2011 | 61 | 0.350 |
Why?
|
| Influenza Vaccines | 1 | 2011 | 51 | 0.350 |
Why?
|
| Blood Glucose | 6 | 2025 | 311 | 0.350 |
Why?
|
| Influenza, Human | 1 | 2011 | 85 | 0.340 |
Why?
|
| Africa South of the Sahara | 4 | 2025 | 13 | 0.330 |
Why?
|
| Maternal Age | 5 | 2022 | 25 | 0.330 |
Why?
|
| Family Characteristics | 3 | 2020 | 47 | 0.330 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2020 | 9 | 0.320 |
Why?
|
| Oryza | 2 | 2024 | 40 | 0.320 |
Why?
|
| Dietary Proteins | 5 | 2020 | 35 | 0.320 |
Why?
|
| Intelligence | 3 | 2016 | 27 | 0.310 |
Why?
|
| Health Promotion | 6 | 2024 | 176 | 0.310 |
Why?
|
| Particulate Matter | 3 | 2024 | 17 | 0.300 |
Why?
|
| Poverty Areas | 1 | 2008 | 9 | 0.290 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2018 | 129 | 0.290 |
Why?
|
| Depression | 2 | 2010 | 215 | 0.280 |
Why?
|
| Trace Elements | 4 | 2016 | 8 | 0.270 |
Why?
|
| Research Design | 3 | 2019 | 182 | 0.270 |
Why?
|
| Diet Surveys | 4 | 2013 | 9 | 0.270 |
Why?
|
| Cluster Analysis | 3 | 2023 | 124 | 0.270 |
Why?
|
| Diarrhea, Infantile | 4 | 2016 | 6 | 0.260 |
Why?
|
| Hospitals | 2 | 2024 | 81 | 0.260 |
Why?
|
| Middle Aged | 13 | 2025 | 7164 | 0.260 |
Why?
|
| Developmental Disabilities | 3 | 2012 | 15 | 0.260 |
Why?
|
| Choline | 2 | 2023 | 19 | 0.250 |
Why?
|
| Risk Reduction Behavior | 2 | 2017 | 46 | 0.250 |
Why?
|
| Reproductive History | 1 | 2025 | 9 | 0.250 |
Why?
|
| Reproduction | 3 | 2020 | 63 | 0.240 |
Why?
|
| Menopause | 1 | 2025 | 30 | 0.240 |
Why?
|
| Food Services | 1 | 2025 | 9 | 0.240 |
Why?
|
| Contraception Behavior | 1 | 2005 | 17 | 0.240 |
Why?
|
| Iodine | 2 | 2021 | 11 | 0.230 |
Why?
|
| Cause of Death | 1 | 2025 | 73 | 0.230 |
Why?
|
| Food | 2 | 2023 | 33 | 0.230 |
Why?
|
| Morbidity | 5 | 2025 | 59 | 0.230 |
Why?
|
| Phylogeny | 3 | 2019 | 480 | 0.220 |
Why?
|
| Interviews as Topic | 4 | 2020 | 156 | 0.220 |
Why?
|
| Niacin | 1 | 2024 | 2 | 0.220 |
Why?
|
| Air Pollutants | 1 | 2024 | 18 | 0.220 |
Why?
|
| Focus Groups | 2 | 2016 | 95 | 0.220 |
Why?
|
| Arachidonic Acid | 2 | 2016 | 18 | 0.220 |
Why?
|
| Child Behavior | 2 | 2016 | 27 | 0.210 |
Why?
|
| Diabetes Mellitus | 2 | 2017 | 215 | 0.210 |
Why?
|
| Infant Formula | 2 | 2021 | 18 | 0.210 |
Why?
|
| Cognition Disorders | 3 | 2017 | 184 | 0.210 |
Why?
|
| Chorioamnionitis | 1 | 2023 | 3 | 0.210 |
Why?
|
| Rotavirus | 1 | 2023 | 1 | 0.210 |
Why?
|
| Global Health | 2 | 2019 | 51 | 0.210 |
Why?
|
| Rotavirus Vaccines | 1 | 2023 | 3 | 0.210 |
Why?
|
| Time Factors | 5 | 2017 | 1593 | 0.210 |
Why?
|
| Treatment Outcome | 4 | 2017 | 2380 | 0.210 |
Why?
|
| Memory, Short-Term | 1 | 2023 | 62 | 0.210 |
Why?
|
| Air Pollution | 1 | 2023 | 18 | 0.200 |
Why?
|
| Infant Mortality | 2 | 2025 | 15 | 0.200 |
Why?
|
| Electric Impedance | 2 | 2020 | 30 | 0.200 |
Why?
|
| Meals | 1 | 2022 | 22 | 0.200 |
Why?
|
| Nutrition Disorders | 1 | 2002 | 2 | 0.200 |
Why?
|
| Developed Countries | 1 | 2002 | 7 | 0.190 |
Why?
|
| Feeding Methods | 2 | 2020 | 2 | 0.190 |
Why?
|
| Case-Control Studies | 3 | 2023 | 722 | 0.190 |
Why?
|
| Cough | 2 | 2012 | 11 | 0.190 |
Why?
|
| Shigella | 1 | 2021 | 2 | 0.190 |
Why?
|
| Cryptosporidiosis | 1 | 2021 | 3 | 0.190 |
Why?
|
| Cryptosporidium | 1 | 2021 | 3 | 0.190 |
Why?
|
| Live Birth | 1 | 2022 | 40 | 0.190 |
Why?
|
| Veterans Health | 3 | 2017 | 6 | 0.190 |
Why?
|
| Appetite | 1 | 2021 | 19 | 0.190 |
Why?
|
| Life Style | 3 | 2017 | 88 | 0.180 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2011 | 18 | 0.180 |
Why?
|
| Pilot Projects | 3 | 2024 | 432 | 0.180 |
Why?
|
| Psychomotor Performance | 2 | 2015 | 72 | 0.180 |
Why?
|
| Pesticide Residues | 1 | 2020 | 2 | 0.180 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2020 | 7 | 0.180 |
Why?
|
| Pesticides | 1 | 2020 | 10 | 0.180 |
Why?
|
| Mycotoxins | 1 | 2020 | 7 | 0.180 |
Why?
|
| Gravidity | 2 | 2010 | 6 | 0.170 |
Why?
|
| Odds Ratio | 3 | 2011 | 237 | 0.170 |
Why?
|
| Malaria | 1 | 2020 | 17 | 0.170 |
Why?
|
| Population Health | 1 | 2020 | 7 | 0.170 |
Why?
|
| Child Nutrition Sciences | 1 | 2020 | 3 | 0.170 |
Why?
|
| World Health Organization | 3 | 2015 | 12 | 0.170 |
Why?
|
| Logistic Models | 3 | 2020 | 407 | 0.170 |
Why?
|
| Asia, Southeastern | 1 | 2020 | 11 | 0.170 |
Why?
|
| Retrospective Studies | 6 | 2023 | 2557 | 0.170 |
Why?
|
| Egypt | 1 | 2019 | 2 | 0.170 |
Why?
|
| Hookworm Infections | 2 | 2014 | 2 | 0.170 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2019 | 3 | 0.170 |
Why?
|
| Triglycerides | 2 | 2015 | 120 | 0.160 |
Why?
|
| Adolescent Behavior | 1 | 2020 | 68 | 0.160 |
Why?
|
| Counseling | 1 | 2019 | 53 | 0.160 |
Why?
|
| Leadership | 1 | 2019 | 53 | 0.160 |
Why?
|
| Potyviridae | 1 | 2019 | 1 | 0.160 |
Why?
|
| Georgia | 3 | 2018 | 22 | 0.160 |
Why?
|
| Adipose Tissue | 2 | 2019 | 184 | 0.160 |
Why?
|
| Biomass | 3 | 2024 | 86 | 0.160 |
Why?
|
| Food Supply | 2 | 2023 | 32 | 0.160 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 67 | 0.160 |
Why?
|
| Infant Health | 1 | 2018 | 2 | 0.160 |
Why?
|
| Data Accuracy | 1 | 2019 | 11 | 0.160 |
Why?
|
| Epidemiological Monitoring | 1 | 2019 | 6 | 0.150 |
Why?
|
| Escherichia coli | 1 | 2021 | 336 | 0.150 |
Why?
|
| Medical Records | 1 | 2019 | 51 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 58 | 0.150 |
Why?
|
| Thiopental | 1 | 1998 | 1 | 0.150 |
Why?
|
| Ceramides | 1 | 2018 | 24 | 0.150 |
Why?
|
| Anesthesia, Obstetrical | 1 | 1998 | 2 | 0.150 |
Why?
|
| Ghana | 3 | 2025 | 7 | 0.150 |
Why?
|
| Anesthesia, Epidural | 1 | 1998 | 7 | 0.150 |
Why?
|
| Home Care Services | 1 | 2018 | 37 | 0.150 |
Why?
|
| Deficiency Diseases | 2 | 2020 | 6 | 0.150 |
Why?
|
| Anesthetics, Intravenous | 1 | 1998 | 15 | 0.150 |
Why?
|
| Xylenes | 1 | 2018 | 2 | 0.150 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 10 | 0.150 |
Why?
|
| Toluene | 1 | 2018 | 11 | 0.150 |
Why?
|
| Efficiency, Organizational | 1 | 2018 | 13 | 0.150 |
Why?
|
| Respiratory Function Tests | 1 | 2018 | 27 | 0.150 |
Why?
|
| Animals | 8 | 2024 | 10399 | 0.150 |
Why?
|
| Nitrogen Oxides | 1 | 2018 | 41 | 0.150 |
Why?
|
| Benzene | 1 | 2018 | 12 | 0.150 |
Why?
|
| Fatty Acids | 1 | 2019 | 204 | 0.140 |
Why?
|
| Program Evaluation | 1 | 2018 | 167 | 0.140 |
Why?
|
| Birth Certificates | 2 | 2019 | 3 | 0.140 |
Why?
|
| Birth Rate | 2 | 2010 | 11 | 0.140 |
Why?
|
| Public Health | 1 | 2018 | 93 | 0.140 |
Why?
|
| Yogurt | 1 | 2017 | 1 | 0.140 |
Why?
|
| Databases, Factual | 2 | 2012 | 255 | 0.140 |
Why?
|
| Stillbirth | 1 | 2017 | 15 | 0.140 |
Why?
|
| Psychosocial Deprivation | 1 | 2017 | 1 | 0.140 |
Why?
|
| Vitamin B Complex | 1 | 2017 | 4 | 0.140 |
Why?
|
| C-Reactive Protein | 3 | 2012 | 92 | 0.140 |
Why?
|
| Regression Analysis | 2 | 2016 | 210 | 0.140 |
Why?
|
| Lyssavirus | 1 | 2017 | 1 | 0.140 |
Why?
|
| Rhabdoviridae Infections | 1 | 2017 | 2 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 523 | 0.140 |
Why?
|
| Chiroptera | 1 | 2017 | 8 | 0.140 |
Why?
|
| Infant, Premature | 3 | 2014 | 133 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 95 | 0.130 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 451 | 0.130 |
Why?
|
| Patient Participation | 1 | 2017 | 56 | 0.130 |
Why?
|
| Psychological Tests | 1 | 2016 | 21 | 0.130 |
Why?
|
| Viral Proteins | 2 | 2019 | 63 | 0.130 |
Why?
|
| Mastication | 1 | 2016 | 4 | 0.130 |
Why?
|
| Evaluation Studies as Topic | 1 | 2016 | 43 | 0.130 |
Why?
|
| Veterans | 1 | 2017 | 69 | 0.130 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 21 | 0.130 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 82 | 0.130 |
Why?
|
| Random Allocation | 1 | 2016 | 151 | 0.120 |
Why?
|
| Risk | 1 | 2016 | 136 | 0.120 |
Why?
|
| Health Priorities | 2 | 2012 | 7 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 207 | 0.120 |
Why?
|
| Organ Size | 1 | 2015 | 85 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 2 | 2014 | 369 | 0.120 |
Why?
|
| Aging | 4 | 2010 | 976 | 0.120 |
Why?
|
| Growth Charts | 1 | 2015 | 3 | 0.120 |
Why?
|
| Waist Circumference | 1 | 2015 | 20 | 0.120 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2015 | 4 | 0.120 |
Why?
|
| Cholesterol, HDL | 1 | 2015 | 59 | 0.120 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 65 | 0.120 |
Why?
|
| Musa | 1 | 2014 | 1 | 0.120 |
Why?
|
| Alleles | 1 | 2016 | 353 | 0.120 |
Why?
|
| Bone Density | 1 | 2016 | 99 | 0.120 |
Why?
|
| Antitubercular Agents | 1 | 2015 | 17 | 0.120 |
Why?
|
| Asia | 2 | 2025 | 20 | 0.120 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2014 | 19 | 0.120 |
Why?
|
| Retinol-Binding Proteins | 1 | 2014 | 7 | 0.120 |
Why?
|
| Body Size | 2 | 2014 | 37 | 0.110 |
Why?
|
| Fever | 2 | 2012 | 31 | 0.110 |
Why?
|
| RNA, Long Noncoding | 1 | 2014 | 31 | 0.110 |
Why?
|
| Incidence | 4 | 2017 | 562 | 0.110 |
Why?
|
| Homologous Recombination | 1 | 2014 | 10 | 0.110 |
Why?
|
| Biopterin | 1 | 2013 | 1 | 0.110 |
Why?
|
| DNA, Viral | 1 | 2014 | 55 | 0.110 |
Why?
|
| Sequence Alignment | 1 | 2014 | 111 | 0.110 |
Why?
|
| Sex Characteristics | 4 | 2019 | 172 | 0.110 |
Why?
|
| Seeds | 1 | 2013 | 12 | 0.110 |
Why?
|
| Women, Working | 1 | 2013 | 4 | 0.110 |
Why?
|
| Dairying | 1 | 2013 | 7 | 0.110 |
Why?
|
| Leg | 1 | 2014 | 134 | 0.110 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 85 | 0.110 |
Why?
|
| Insulin | 1 | 2015 | 315 | 0.110 |
Why?
|
| HIV Infections | 1 | 1995 | 157 | 0.100 |
Why?
|
| Haplotypes | 1 | 2014 | 283 | 0.100 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2013 | 7 | 0.100 |
Why?
|
| Menarche | 2 | 2025 | 8 | 0.100 |
Why?
|
| Base Sequence | 1 | 2014 | 584 | 0.100 |
Why?
|
| Nervous System | 1 | 2012 | 12 | 0.100 |
Why?
|
| Age Factors | 4 | 2019 | 733 | 0.100 |
Why?
|
| Equipment Safety | 1 | 2012 | 19 | 0.100 |
Why?
|
| Adsorption | 1 | 2012 | 32 | 0.100 |
Why?
|
| Iron Compounds | 1 | 2012 | 4 | 0.100 |
Why?
|
| Regional Health Planning | 1 | 2012 | 3 | 0.100 |
Why?
|
| Equipment Failure | 1 | 2012 | 31 | 0.100 |
Why?
|
| Patient Safety | 1 | 2012 | 38 | 0.100 |
Why?
|
| alpha Karyopherins | 1 | 2012 | 1 | 0.100 |
Why?
|
| Begomovirus | 1 | 2012 | 1 | 0.100 |
Why?
|
| Nuclear Localization Signals | 1 | 2012 | 9 | 0.100 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1050 | 0.090 |
Why?
|
| Copper | 1 | 2012 | 47 | 0.090 |
Why?
|
| Equipment Design | 1 | 2012 | 217 | 0.090 |
Why?
|
| Respiratory Sounds | 1 | 2011 | 5 | 0.090 |
Why?
|
| Intention to Treat Analysis | 1 | 2011 | 13 | 0.090 |
Why?
|
| Contraceptives, Oral | 2 | 2002 | 23 | 0.090 |
Why?
|
| Ascorbic Acid | 2 | 2002 | 24 | 0.090 |
Why?
|
| Plant Proteins | 1 | 2012 | 64 | 0.090 |
Why?
|
| Linoleic Acid | 1 | 2011 | 1 | 0.090 |
Why?
|
| Skinfold Thickness | 2 | 2014 | 19 | 0.090 |
Why?
|
| Body Constitution | 2 | 2003 | 11 | 0.090 |
Why?
|
| Health Behavior | 2 | 2017 | 156 | 0.090 |
Why?
|
| Depression, Postpartum | 1 | 2011 | 15 | 0.090 |
Why?
|
| Students | 2 | 2025 | 196 | 0.090 |
Why?
|
| Social Behavior Disorders | 1 | 2010 | 2 | 0.090 |
Why?
|
| Age Distribution | 3 | 2006 | 73 | 0.090 |
Why?
|
| Kenya | 4 | 2013 | 34 | 0.090 |
Why?
|
| Eating | 2 | 2024 | 70 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2025 | 611 | 0.080 |
Why?
|
| Quality of Life | 1 | 2013 | 491 | 0.080 |
Why?
|
| Urban Population | 1 | 2010 | 78 | 0.080 |
Why?
|
| Mental Disorders | 1 | 2010 | 110 | 0.080 |
Why?
|
| Puerperal Disorders | 1 | 2009 | 14 | 0.080 |
Why?
|
| Fetal Blood | 1 | 2009 | 38 | 0.080 |
Why?
|
| Minerals | 1 | 2009 | 15 | 0.080 |
Why?
|
| Infant Care | 1 | 2009 | 6 | 0.080 |
Why?
|
| Clinical Trials as Topic | 2 | 2016 | 215 | 0.080 |
Why?
|
| Income | 2 | 2006 | 38 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 112 | 0.070 |
Why?
|
| Indians, North American | 1 | 2012 | 517 | 0.070 |
Why?
|
| Educational Measurement | 1 | 2008 | 128 | 0.070 |
Why?
|
| Intelligence Tests | 3 | 2012 | 25 | 0.070 |
Why?
|
| Protoporphyrins | 2 | 2012 | 12 | 0.070 |
Why?
|
| Lycopersicon esculentum | 1 | 2006 | 3 | 0.070 |
Why?
|
| Capsid Proteins | 1 | 2006 | 12 | 0.070 |
Why?
|
| Hygiene | 1 | 2006 | 36 | 0.060 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2016 | 26 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 198 | 0.060 |
Why?
|
| Marital Status | 1 | 2005 | 16 | 0.060 |
Why?
|
| Urban Health | 1 | 2005 | 14 | 0.060 |
Why?
|
| Brain | 1 | 2011 | 739 | 0.060 |
Why?
|
| Vitamin D | 2 | 2016 | 49 | 0.060 |
Why?
|
| Diet Records | 2 | 2017 | 10 | 0.060 |
Why?
|
| Abortion, Induced | 1 | 2005 | 17 | 0.060 |
Why?
|
| Child Mortality | 1 | 2025 | 4 | 0.060 |
Why?
|
| Autopsy | 1 | 2025 | 25 | 0.060 |
Why?
|
| Physical Fitness | 1 | 2005 | 62 | 0.060 |
Why?
|
| Data Collection | 1 | 2005 | 106 | 0.060 |
Why?
|
| Africa | 1 | 2004 | 16 | 0.060 |
Why?
|
| Dietary Carbohydrates | 2 | 2015 | 26 | 0.060 |
Why?
|
| Magnesium | 1 | 2024 | 42 | 0.050 |
Why?
|
| Hospitals, Public | 1 | 2023 | 3 | 0.050 |
Why?
|
| Cambodia | 1 | 2023 | 10 | 0.050 |
Why?
|
| Dietary Fats | 2 | 2015 | 59 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 9 | 0.050 |
Why?
|
| Soot | 1 | 2023 | 1 | 0.050 |
Why?
|
| Milk | 2 | 2013 | 21 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 167 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 605 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2024 | 87 | 0.050 |
Why?
|
| Parturition | 1 | 2023 | 16 | 0.050 |
Why?
|
| Walking | 1 | 2004 | 135 | 0.050 |
Why?
|
| Carbon Monoxide | 1 | 2023 | 47 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 92 | 0.050 |
Why?
|
| ROC Curve | 2 | 2014 | 141 | 0.050 |
Why?
|
| Self Report | 2 | 2013 | 120 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 6 | 0.050 |
Why?
|
| Models, Statistical | 3 | 2010 | 128 | 0.050 |
Why?
|
| Antinematodal Agents | 1 | 2002 | 3 | 0.050 |
Why?
|
| Ascariasis | 1 | 2002 | 2 | 0.050 |
Why?
|
| Phenylalanine | 1 | 2022 | 24 | 0.050 |
Why?
|
| Alkaline Phosphatase | 2 | 2013 | 31 | 0.050 |
Why?
|
| Trichuriasis | 1 | 2002 | 5 | 0.050 |
Why?
|
| Health Planning Guidelines | 1 | 2002 | 6 | 0.050 |
Why?
|
| Adaptation, Ocular | 1 | 2002 | 7 | 0.050 |
Why?
|
| National Health Programs | 1 | 2002 | 4 | 0.050 |
Why?
|
| Body Weights and Measures | 2 | 2018 | 18 | 0.050 |
Why?
|
| Darkness | 1 | 2002 | 17 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2023 | 89 | 0.050 |
Why?
|
| Mebendazole | 1 | 2002 | 10 | 0.050 |
Why?
|
| Methionine | 1 | 2022 | 37 | 0.050 |
Why?
|
| Avitaminosis | 1 | 2002 | 2 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 57 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 345 | 0.050 |
Why?
|
| Thailand | 2 | 2012 | 12 | 0.050 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2021 | 12 | 0.050 |
Why?
|
| Cholesterol | 1 | 2002 | 200 | 0.050 |
Why?
|
| Smoking | 1 | 2005 | 473 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2002 | 242 | 0.040 |
Why?
|
| Immunoradiometric Assay | 1 | 2000 | 1 | 0.040 |
Why?
|
| Transferrin | 1 | 2000 | 10 | 0.040 |
Why?
|
| Colorimetry | 1 | 2000 | 15 | 0.040 |
Why?
|
| Exercise | 1 | 2005 | 482 | 0.040 |
Why?
|
| Fluorometry | 1 | 2000 | 8 | 0.040 |
Why?
|
| Food Contamination | 1 | 2020 | 22 | 0.040 |
Why?
|
| Malawi | 1 | 2020 | 3 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 20 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 25 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2000 | 129 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2020 | 100 | 0.040 |
Why?
|
| Coitus | 1 | 1999 | 14 | 0.040 |
Why?
|
| Labor, Obstetric | 1 | 1999 | 11 | 0.040 |
Why?
|
| Polyproteins | 1 | 2019 | 1 | 0.040 |
Why?
|
| Genome Size | 1 | 2019 | 8 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2019 | 38 | 0.040 |
Why?
|
| Vermont | 1 | 2019 | 1 | 0.040 |
Why?
|
| Ideal Body Weight | 1 | 2018 | 2 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 18 | 0.040 |
Why?
|
| Tobacco | 2 | 2012 | 87 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 475 | 0.040 |
Why?
|
| Cephalometry | 1 | 2018 | 28 | 0.040 |
Why?
|
| Checklist | 1 | 2018 | 22 | 0.040 |
Why?
|
| Health Status | 1 | 1999 | 148 | 0.040 |
Why?
|
| Freezing | 1 | 1998 | 21 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2018 | 12 | 0.040 |
Why?
|
| Sample Size | 1 | 2018 | 17 | 0.040 |
Why?
|
| Quality Control | 1 | 2018 | 21 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 74 | 0.040 |
Why?
|
| Maternal Health | 1 | 2018 | 4 | 0.040 |
Why?
|
| Executive Function | 1 | 2018 | 25 | 0.040 |
Why?
|
| Work Capacity Evaluation | 1 | 1998 | 1 | 0.040 |
Why?
|
| Powders | 1 | 2017 | 19 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 134 | 0.030 |
Why?
|
| Software | 1 | 2018 | 125 | 0.030 |
Why?
|
| Preventive Health Services | 1 | 2017 | 16 | 0.030 |
Why?
|
| Rabies | 1 | 2017 | 1 | 0.030 |
Why?
|
| Rabies virus | 1 | 2017 | 1 | 0.030 |
Why?
|
| Portion Size | 1 | 2017 | 6 | 0.030 |
Why?
|
| Social Environment | 1 | 2017 | 56 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2017 | 66 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 521 | 0.030 |
Why?
|
| Demography | 1 | 2017 | 94 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2018 | 191 | 0.030 |
Why?
|
| Mental Recall | 1 | 2017 | 45 | 0.030 |
Why?
|
| Candy | 1 | 2016 | 2 | 0.030 |
Why?
|
| Dairy Products | 1 | 2016 | 5 | 0.030 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2016 | 1 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1995 | 13 | 0.030 |
Why?
|
| Emigration and Immigration | 2 | 2005 | 9 | 0.030 |
Why?
|
| Sex Distribution | 2 | 2005 | 78 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 1995 | 39 | 0.030 |
Why?
|
| Outpatients | 1 | 2015 | 44 | 0.030 |
Why?
|
| Calcium | 1 | 2016 | 235 | 0.030 |
Why?
|
| Fetal Nutrition Disorders | 1 | 2014 | 1 | 0.030 |
Why?
|
| Bolivia | 1 | 2014 | 3 | 0.030 |
Why?
|
| Wasting Syndrome | 1 | 2014 | 7 | 0.030 |
Why?
|
| Community Health Centers | 1 | 2014 | 14 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1995 | 390 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 226 | 0.030 |
Why?
|
| Th1-Th2 Balance | 1 | 2013 | 3 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2013 | 6 | 0.030 |
Why?
|
| Placebos | 1 | 2013 | 47 | 0.030 |
Why?
|
| Georgia (Republic) | 1 | 2013 | 1 | 0.030 |
Why?
|
| Serum Albumin | 1 | 2013 | 35 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2013 | 289 | 0.030 |
Why?
|
| Bias | 1 | 2013 | 42 | 0.030 |
Why?
|
| Health Surveys | 1 | 2013 | 82 | 0.030 |
Why?
|
| Carbonated Beverages | 1 | 2012 | 3 | 0.030 |
Why?
|
| Hemoglobin A | 1 | 2012 | 2 | 0.020 |
Why?
|
| Adolescent Health Services | 1 | 2012 | 3 | 0.020 |
Why?
|
| Child Health Services | 1 | 2012 | 7 | 0.020 |
Why?
|
| Ethiopia | 1 | 2012 | 9 | 0.020 |
Why?
|
| Nigeria | 1 | 2012 | 20 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2012 | 17 | 0.020 |
Why?
|
| Acute-Phase Proteins | 1 | 2011 | 4 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 66 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 95 | 0.020 |
Why?
|
| Cattle | 1 | 2013 | 389 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 147 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 157 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2011 | 43 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2010 | 14 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 656 | 0.020 |
Why?
|
| Anxiety | 1 | 2010 | 146 | 0.020 |
Why?
|
| Weaning | 1 | 2009 | 18 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 243 | 0.020 |
Why?
|
| Beverages | 1 | 2008 | 24 | 0.020 |
Why?
|
| Aged | 1 | 2017 | 5416 | 0.020 |
Why?
|
| Urbanization | 1 | 2006 | 8 | 0.020 |
Why?
|
| Agrobacterium tumefaciens | 1 | 2006 | 5 | 0.020 |
Why?
|
| Plants, Genetically Modified | 1 | 2006 | 23 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2006 | 23 | 0.020 |
Why?
|
| Drinking | 1 | 2006 | 8 | 0.020 |
Why?
|
| Maternal Behavior | 1 | 2006 | 9 | 0.020 |
Why?
|
| RNA Stability | 1 | 2006 | 29 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2006 | 25 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 101 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 112 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2006 | 86 | 0.020 |
Why?
|
| Hand Disinfection | 1 | 2006 | 37 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2005 | 17 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 51 | 0.010 |
Why?
|
| Birth Order | 1 | 2004 | 5 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 402 | 0.010 |
Why?
|
| Intergenerational Relations | 1 | 2004 | 11 | 0.010 |
Why?
|
| Motor Activity | 1 | 2004 | 147 | 0.010 |
Why?
|
| Ascaris lumbricoides | 1 | 2002 | 2 | 0.010 |
Why?
|
| Trichuris | 1 | 2002 | 5 | 0.010 |
Why?
|
| Feces | 1 | 2002 | 109 | 0.010 |
Why?
|
| Honduras | 1 | 2000 | 2 | 0.010 |
Why?
|